DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zofran (Ondansetron) - Nausea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Nausea (31)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zofran (Ondansetron) where reactions include nausea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 31   Next >>

Possible Zofran side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-22

Patient: 67 year old female

Reactions: Fatigue, Nausea, Herpes Zoster

Drug(s) suspected as cause:
Ebastine
    Dosage: 10 mg, unk
    Indication: Faecaloma

Ebastine
    Indication: Pruritus

Halaven
    Dosage: unk
    Indication: Faecaloma
    Start date: 2012-06-19

Halaven
    Dosage: 1.58 mg, unk
    Indication: Pruritus
    Start date: 2012-06-26

Loratadine
    Indication: Pruritus

Loratadine
    Indication: Faecaloma

Neulasta
    Indication: Pruritus

Neulasta
    Dosage: unk
    Indication: Faecaloma

Solu-Medrol
    Dosage: 20 mg, unk
    Indication: Faecaloma
    Start date: 2012-06-26

Solu-Medrol
    Indication: Pruritus

Zantac
    Indication: Pruritus

Zantac
    Dosage: 50 mg, unk
    Indication: Faecaloma
    Start date: 2012-06-26

Zofran
    Dosage: 8 mg, unk
    Indication: Faecaloma
    Start date: 2012-06-26

Zofran
    Indication: Pruritus

Other drugs received by patient: Acebutolol; Nexium



Possible Zofran side effects in female

Reported by a consumer/non-health professional from France on 2012-08-21

Patient: female

Reactions: Fatigue, Nausea, Herpes Zoster

Drug(s) suspected as cause:
Ebsatine
    Indication: Faecaloma

Ebsatine
    Indication: Pruritus

Halaven
    Dosage: 1.58 mg/day
    Start date: 2012-06-26

Halaven
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-19

Loratadine
    Indication: Pruritus

Loratadine
    Indication: Faecaloma

Neulasta
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-27

Solu-Medrol
    Dosage: 20 mg/day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Zantac
    Dosage: 50 mg/day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Zofran
    Dosage: 8 mg/day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Other drugs received by patient: Acebutolol; Nexium



Possible Zofran side effects in female

Reported by a physician from France on 2012-08-15

Patient: female

Reactions: Fatigue, Pruritus, Nausea, Faecaloma, Herpes Zoster

Drug(s) suspected as cause:
Ebastine
    Indication: Pruritus

Halaven
    Dosage: 1.58mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Loratadine
    Indication: Pruritus

Neulasta
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-27

Solu-Medrol
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Zantac
    Dosage: 50mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Zofran
    Dosage: 8mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-06-26

Other drugs received by patient: Cyclophosphamide; Fluorouracil; Methotrexate; Nexium; Bevacizumab; Doxorubicin HCL; Acebutolol



Possible Zofran side effects in 54 year old female

Reported by a physician from United States on 2012-08-13

Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)

Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleve
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-13

Doxycycline HCL
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-20

Motrin
    Administration route: Oral
    Indication: Pain
    Start date: 2011-12-19
    End date: 2012-06-11

MS Contin
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-12

Unknown Medication
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-18

Zofran
    Indication: Nausea
    Start date: 2012-06-17
    End date: 2012-06-19

Other drugs received by patient: Vitamin B-12; Ascorbic Acid; Pamidronate Disodium; Vitamine E; Multiple Vitamin; Folic Acid; Vitamin D



Possible Zofran side effects in 54 year old female

Reported by a physician from United States on 2012-07-17

Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)

Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleve
    Dosage: 220 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-13

Doxycycline
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-20

Motrin
    Dosage: 800 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-12-19
    End date: 2012-06-12

MS Contin
    Dosage: 15 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-12

Study Drug
    Dosage: 45 mg, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-18

Zofran
    Dosage: 4 mg, q6h
    Indication: Nausea
    Start date: 2012-06-17
    End date: 2012-06-19

Other drugs received by patient: Theragran-M / 00610701 /; Vitamin D; Folic Acid; B12 / 00056201 /; Vitamin C / 00008001 /; Pamidronate Disodium; Vitamin E / 00110501 /



Possible Zofran side effects in 54 year old female

Reported by a physician from United States on 2012-07-13

Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)

Reactions: Vomiting, Diarrhoea, Nausea, Dehydration, Blood Creatine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleve
    Dosage: 220 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-13

Doxycycline
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-20

Motrin
    Dosage: 800 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-12-19
    End date: 2012-06-12

MS Contin
    Dosage: 15 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-12

Study Drug
    Dosage: 45 mg, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-18

Zofran
    Dosage: 4 mg, q6h
    Indication: Nausea
    Start date: 2012-06-17
    End date: 2012-06-19

Other drugs received by patient: Vitamin D; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin C / 00008001 /; Vitamin E / 00110501 /; Pamidronate Disodium; Folic Acid



Possible Zofran side effects in male

Reported by a physician from Belgium on 2012-07-09

Patient: male, weighing 73.0 kg (160.6 pounds)

Reactions: Colitis Ischaemic, Vomiting, Nausea, Rectal Haemorrhage, Constipation, Faecaloma, Diarrhoea, Abdominal Symptom, Diarrhoea Haemorrhagic, Feeling of Body Temperature Change, Muscle Spasms, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Testicular Neoplasm
    Start date: 2012-04-17
    End date: 2012-05-08

Zofran
    Start date: 2012-04-17
    End date: 2012-05-08

Zofran
    Dosage: 8mg twice per day
    Administration route: Oral
    Indication: Nausea
    Start date: 2012-04-18
    End date: 2012-05-11

Other drugs received by patient: Solu-Medrol; Medrol



Possible Zofran side effects in 54 year old female

Reported by a physician from United States on 2012-07-06

Patient: 54 year old female, weighing 55.8 kg (122.7 pounds)

Reactions: Vomiting, Nausea, Diarrhoea, Dehydration, Blood Creatine Increased, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aleve
    Dosage: 220 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-13

Doxycycline Hyclate
    Dosage: 100 mg, bid
    Administration route: Oral
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-20

Motrin
    Dosage: 800 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2011-12-19
    End date: 2012-06-12

MS Contin
    Dosage: 15 mg, bid
    Administration route: Oral
    Indication: Pain
    Start date: 2012-06-12
    End date: 2012-06-12

Study Drug
    Dosage: 45 mg, unk
    Indication: non-Small Cell Lung Cancer
    Start date: 2012-05-29
    End date: 2012-06-18

Zofran
    Dosage: 4 mg, q6h
    Indication: Nausea
    Start date: 2012-06-17
    End date: 2012-06-19

Other drugs received by patient: Pamidronate Disodium; Folic Acid; Theragran-M / 00610701 /; B12 / 00056201 /; Vitamin E / 00110501 /; Vitamin C / 00008001 /; Vitamin D



Possible Zofran side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19

Patient: 65 year old female

Reactions: Blood Bilirubin Increased, Weight Decreased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Dysphagia, Blood Urine Present, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Dysuria, Hypophagia, Feeling Abnormal, DRY Eye, Asthenia, Leukopenia

Drug(s) suspected as cause:
Aspirin
    Dosage: 81 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2A
    Dosage: qw;sc
    Indication: Product Used FOR Unknown Indication

Pradaxa
    Dosage: 150 mg;bid;po 75 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Rythmol
    Dosage: 325 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg;qd;po 25 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mg;prn;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Metoclopramide Hydrochloride; Reglan



Possible Zofran side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19

Patient: 65 year old female

Reactions: Weight Decreased, Blood Bilirubin Increased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Hypophagia, Alopecia, Dysuria, Feeling Abnormal, Asthenia, DRY Eye, Leukopenia

Drug(s) suspected as cause:
Acetaminophen
    Indication: Product Used FOR Unknown Indication

Aspirin
    Dosage: 81 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2A
    Dosage: qw; sc
    Indication: Product Used FOR Unknown Indication

Pradaxa
    Dosage: 150 mg; bid; po, 75 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 600 mg; bid; po
    Administration route: Oral

Rythmol
    Dosage: 325 mg; bid; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg; qd; po, 25 mg; qd; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg; tid; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mcg; prn; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Hydrochloride; Reglan; Metoclopramide



Possible Zofran side effects in 76 year old female

Reported by a physician from Austria on 2012-05-24

Patient: 76 year old female, weighing 85.0 kg (187.0 pounds)

Reactions: Blood Pressure Systolic Decreased, Nausea

Drug(s) suspected as cause:
Zofran



Possible Zofran side effects in 83 year old female

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-05-08

Patient: 83 year old female

Reactions: Vomiting, Nausea, Bacteraemia, Staphylococcal Infection, International Normalised Ratio Increased, Gastroenteritis Viral, Spondylitis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Dosage: 10 mg, daily dose, long term
    Administration route: Oral

Sintrom
    Dosage: 3 mg, daily
    Administration route: Oral
    Indication: Atrial Fibrillation
    End date: 2012-02-20

Torsemide
    Dosage: 10 mg, daily dose, long term
    Administration route: Oral

Zofran
    Indication: Vomiting

Zofran
    Dosage: 4 mg, per 8 hours
    Indication: Nausea
    Start date: 2012-02-15
    End date: 2012-03-04

Other drugs received by patient: Floxapen; Digoxin; Calcimagon-D3; Morphin HCL; Zolpidem; Laxoberon; Digoxin



Possible Zofran side effects in 48 year old female

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: 48 year old female

Reactions: Vomiting, Nausea, Diarrhoea, Urinary Tract Infection, Constipation, Skin Reaction

Drug(s) suspected as cause:
Ondansetron
    Dosage: 8mg as required
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2009-11-30

Tykerb
    Dosage: 1250mg per day
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-01-01

Zofran
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2000-01-01
    End date: 2000-08-01

Other drugs received by patient: Xeloda; Steroid; Omeprazole; Coumadin; Chemotherapy



Possible Zofran side effects in 58 year old female

Reported by a physician from United States on 2012-04-27

Patient: 58 year old female

Reactions: Nasopharyngitis, Malaise, Vomiting, Nausea, Drug Ineffective, Ill-Defined Disorder, Cough

Drug(s) suspected as cause:
Advair Diskus 100 / 50

Avandamet
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Chemotherapy

Zofran
    Dosage: 8mg unknown
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Zofran side effects in 78 year old female

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: 78 year old female

Reactions: Vomiting, Nausea, Drug Ineffective, Abdominal Distension, Rash, Gastric Disorder

Drug(s) suspected as cause:
Cinryze
    Dosage: 1000unit three times per week
    Indication: Angioedema
    Start date: 2006-01-01

Zofran
    Indication: Vomiting



Possible Zofran side effects in

Reported by a consumer/non-health professional from United States on 2012-04-27

Patient: , weighing 79.5 kg (174.9 pounds)

Reactions: Weight Decreased, Pruritus, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Photophobia, Product Quality Issue, Blood Urine Present, Dysphagia, Stomatitis, Nausea, Underdose, Poor Quality Drug Administered, Eye Pain, Dysgeusia, Blood Glucose Decreased, Bladder Spasm, Vaginal Inflammation, Alopecia, DRY Eye, Asthenia

Drug(s) suspected as cause:
Rythmol SR
    Indication: Product Used FOR Unknown Indication

Zofran
    Indication: Product Used FOR Unknown Indication



Possible Zofran side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03

Patient: 65 year old female

Reactions: Blood Bilirubin Increased, Weight Decreased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Stomatitis, Dysphagia, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Hypophagia, Dysuria, DRY Eye, Feeling Abnormal, Asthenia, Leukopenia

Drug(s) suspected as cause:
Aspirin
    Dosage: 81 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2A
    Dosage: ;qw;sc
    Indication: Product Used FOR Unknown Indication

Pradaxa
    Dosage: 150 mg;bid;po 75 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Rythmol
    Dosage: 325 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg;qd;po 25 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Tylenol (Caplet)
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mg;prn;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Metoclopramide; Hydrochloride; Reglan



Possible Zofran side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03

Patient: 65 year old female

Reactions: Blood Bilirubin Increased, Weight Decreased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Dysuria, Hypophagia, Asthenia, DRY Eye, Feeling Abnormal, Leukopenia

Drug(s) suspected as cause:
Aspirin
    Dosage: 81 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2A
    Dosage: ;qw;sc

Pradaxa
    Dosage: 150 mg;bid;po 75 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral

Rythmol
    Dosage: 325 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg;qd;po 25 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Tylenol (Caplet)
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mg;prn;po
    Administration route: Oral

Other drugs received by patient: Hydrochloride; Metoclopramide; Reglan



Possible Zofran side effects in male

Reported by a physician from France on 2012-04-02

Patient: male, weighing 63.0 kg (138.6 pounds)

Reactions: Abdominal Pain, Nausea, Intestinal Obstruction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acetaminophen and Tramadol HCL
    Dosage: 1unit twice per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-06
    End date: 2012-02-15

Morphine Sulfate
    Dosage: 30mg per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-06
    End date: 2012-02-15

Zofran
    Dosage: 8mg twice per day
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-06
    End date: 2012-02-15

Other drugs received by patient: Debridat; Spasfon; Doxorubicin HCL; Isentress; Vinblastine Sulfate; Norvir; Creon; Motilium; Bactrim DS; Polaramine; Duspatalin; Prezista; Valacyclovir Hydrochloride; Dacarbazine; Bleomycin Sulfate; Emend; Intelence



Possible Zofran side effects in female

Reported by a consumer/non-health professional from Australia on 2012-03-22

Patient: female, weighing 53.0 kg (116.6 pounds)

Reactions: Nausea, Maternal Exposure During Pregnancy, Dehydration

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zofran



Possible Zofran side effects in 66 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-22

Patient: 66 year old female, weighing 59.4 kg (130.7 pounds)

Reactions: Confusional State, Abdominal Pain, Vomiting, Blood Urea Increased, Nausea, Mental Status Changes, Cognitive Disorder, Headache, Pallor, Malaise, Fatigue, Posterior Reversible Encephalopathy Syndrome, Disturbance in Attention, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Colace (Docusate Sodium)
    Dosage: 100 mg, bid
    Indication: Constipation
    Start date: 2009-04-02
    End date: 2009-08-28

Ferrous Gluconate (Ferrous Gluconate) Tablet
    Dosage: 325 mg, bid, oral
    Administration route: Oral
    Indication: Iron Deficiency
    Start date: 2009-02-27
    End date: 2009-08-28

Lortab
    Dosage: 1 df every 6 hours as needed
    Indication: Analgesic Therapy
    Start date: 2009-08-25
    End date: 2009-08-28

Lortab
    Dosage: 1 df every 6 hours as needed
    Indication: Analgesic Therapy
    Start date: 2009-04-02
    End date: 2009-06-29

Megace
    Dosage: 3 df, qd, oral
    Administration route: Oral
    Indication: Appetite Disorder

Pioglitazone
    Dosage: 30 mg, qd, oral
    Administration route: Oral
    Indication: Diabetes Mellitus
    Start date: 2007-06-04

Ranitidine
    Dosage: 150 mg, bid
    Indication: Ulcer
    End date: 2009-08-28

Simvastatin
    Dosage: 40 mg, bid
    Indication: Blood Cholesterol
    Start date: 2009-02-27
    End date: 2009-08-28

Sunitinib Malate
    Dosage: 50 mg, bid
    Indication: Renal Cancer
    Start date: 2009-06-01
    End date: 2009-08-28

Uncodeable ^investigational Drug^ (Uncodeable ^investigational Drug^)
    Indication: Prophylaxis
    Start date: 2009-05-12
    End date: 2009-07-07

Uncodeable ^unclassifiable^ (Uncodeable ^unclassifiable^)
    Dosage: qd 5 days a week x 3 weeks
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-03-16
    End date: 2009-04-06

Zofran
    Dosage: 1 df every 6 hours as needed, oral
    Administration route: Oral
    Indication: Nausea
    End date: 2009-08-28

Other drugs received by patient: Artificial Tears; Aspirin; Actonel



Possible Zofran side effects in female

Reported by a consumer/non-health professional from Australia on 2012-03-05

Patient: female

Reactions: Nausea, Dehydration, Maternal Exposure During Pregnancy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Zofran



Possible Zofran side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-14

Patient: 34 year old female, weighing 74.8 kg (164.6 pounds)

Reactions: Drug Ineffective, Nausea, Vomiting Projectile, Headache, Hypoaesthesia, Aggression, Disturbance in Attention, Anger, Memory Impairment

Drug(s) suspected as cause:
Butalbital Acetaminophen Caffeine
    Indication: Headache

Lortab
    Indication: Headache

Phenergan
    Indication: Vomiting Projectile
    Start date: 2011-01-01

Phenergan
    Indication: Nausea
    Start date: 2011-01-01

Pristiq
    Dosage: extended release tablet 100 mg to 50 mg weaning dose
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Pristiq
    Dosage: extended release tablet 50 mg splitted
    Administration route: Oral
    Start date: 2011-01-01

Pristiq
    Dosage: extended release tablet
    Administration route: Oral
    Indication: Insomnia
    Start date: 2011-06-01

Pristiq
    Dosage: extended release tablet 100 mg to 50 mg weaning dose
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Pristiq
    Dosage: extended release tablet
    Administration route: Oral
    Indication: Stress AT Work
    Start date: 2011-06-01

Pristiq
    Dosage: extended release tablet 50 mg splitted
    Administration route: Oral
    Start date: 2011-01-01

Xanax
    Administration route: Oral
    Indication: Sleep Disorder

Zofran
    Indication: Nausea
    Start date: 2011-01-01

Zofran
    Indication: Vomiting Projectile
    Start date: 2011-01-01



Possible Zofran side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-14

Patient: female, weighing 74.8 kg (164.6 pounds)

Reactions: Nausea, Vomiting Projectile, Drug Ineffective, Headache, Aggression, Anger, Disturbance in Attention, Nervous System Disorder, Drug Administration Error, Memory Impairment

Drug(s) suspected as cause:
Fioricet
    Dosage: unk
    Administration route: Oral
    Indication: Headache

Lortab
    Dosage: unk
    Indication: Headache

Pristiq
    Indication: Insomnia

Pristiq
    Dosage: 100 mg, daily
    Indication: Stress AT Work
    Start date: 2011-06-01

Promethazine
    Indication: Nausea

Promethazine
    Dosage: unk
    Indication: Vomiting Projectile

Xanax
    Dosage: unk
    Indication: Insomnia

Zofran
    Indication: Nausea

Zofran
    Dosage: unk
    Indication: Vomiting Projectile



Possible Zofran side effects in 74 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01

Patient: 74 year old female

Reactions: Anxiety, Torsade DE Pointes, Nausea, Hypomagnesaemia, Pain, Atrioventricular Block First Degree, Hypokalaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Amiodarone HCL
    Indication: Ventricular Tachycardia

Carvedilol
    Indication: Product Used FOR Unknown Indication

Citalopram Hydrobromide
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 4 mg, intravenous
    Indication: Nausea

Other drugs received by patient: Fentanyl



Possible Zofran side effects in 74 year old female

Reported by a consumer/non-health professional from United States on 2012-01-18

Patient: 74 year old female

Reactions: Nausea, Pain, Treatment Noncompliance, Long QT Syndrome, Sinus Bradycardia, Hypokalaemia, Torsade DE Pointes, Anxiety, Hypomagnesaemia, Atrioventricular Block First Degree

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Amiodarone HCL
    Indication: Ventricular Tachycardia

Carvedilol
    Indication: Product Used FOR Unknown Indication

Citalopram Hydrobromide
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: (4 mg), intravenous
    Indication: Nausea

Other drugs received by patient: Fentanyl



Possible Zofran side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-12

Patient: female, weighing 74.8 kg (164.6 pounds)

Reactions: Nausea, Vomiting Projectile, Drug Ineffective, Hypoaesthesia, Headache, Aggression, Disturbance in Attention, Anger, Memory Impairment

Drug(s) suspected as cause:
Fioricet
    Dosage: unk
    Indication: Headache

Lortab
    Dosage: unk
    Indication: Headache

Pristiq
    Dosage: unk
    Administration route: Oral
    Indication: Insomnia
    Start date: 2011-01-01

Pristiq
    Dosage: 100 mg,daily
    Administration route: Oral
    Indication: Stress AT Work
    Start date: 2011-06-01
    End date: 2011-01-01

Promethazine
    Indication: Vomiting Projectile

Promethazine
    Dosage: unk
    Indication: Nausea

Xanax
    Dosage: unk
    Administration route: Oral
    Indication: Sleep Disorder

Zofran
    Indication: Nausea

Zofran
    Dosage: unk
    Indication: Vomiting Projectile



Possible Zofran side effects in 64 year old female

Reported by a consumer/non-health professional from United States on 2012-01-09

Patient: 64 year old female, weighing 59.0 kg (129.8 pounds)

Reactions: Abdominal Pain, Thrombosis, Contusion, Headache, Constipation, Erythema, Hunger, Hot Flush, Oedema Peripheral, DRY Mouth, Nail Disorder, Dizziness, Decreased Appetite, Epistaxis, Vomiting, Pain in Extremity, Nausea, Hypoaesthesia, DRY Skin, Gastric Haemorrhage, Dysgeusia, Lung Disorder, Syncope, Neoplasm Malignant, Ageusia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: no of treatments:6,restarted in aug-2011, 02sep11
    Indication: Breast Cancer in Situ
    Start date: 2007-11-20

Lovenox

Paclitaxel
    Indication: Breast Cancer in Situ

Paclitaxel
    Dosage: no of treatments:6,restarted in aug-2011, 02sep11
    Indication: Breast Cancer in Situ

Platinol
    Dosage: no of treatments:6,restarted in aug-2011,
    Indication: Breast Cancer in Situ
    Start date: 2007-11-20

Zofran
    Indication: Premedication

Other drugs received by patient: Iron; Vitamin D; Multi-Vitamins



Possible Zofran side effects in 65 year old female

Reported by a individual with unspecified qualification from United States on 2011-12-16

Patient: 65 year old female

Reactions: Weight Decreased, Blood Bilirubin Increased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Dysuria, Alopecia, Hypophagia, Asthenia, Feeling Abnormal, DRY Eye, Leukopenia

Drug(s) suspected as cause:
Acetaminophen
    Indication: Product Used FOR Unknown Indication

Aspirin
    Dosage: 81 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Cozaar
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nuvigil
    Dosage: 50 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2A
    Dosage: ;qw;sc

Pradaxa
    Dosage: 150 mg;bid;po, 75 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral

Rythmol
    Dosage: 325 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: 50 mg;qd;po, 25 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 800 mg;tid;po
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 8 mg; pan; po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Metoclopramide HCL; Reglan



Possible Zofran side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-21

Patient: female, weighing 59.4 kg (130.7 pounds)

Reactions: Confusional State, Abdominal Pain, Vomiting, Nausea, Mental Status Changes, Cognitive Disorder, Headache, Fatigue, Malaise

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Amlodipine
    Dosage: 10 mg (10 mg, 1 in 1 d) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Carvedilol
    Dosage: 50 mg (25 mg, 2 in 1 d), unknown
    Indication: Product Used FOR Unknown Indication

Colace (Docusate Sodium)
    Dosage: 200 mg (100 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication

Fergon (Ferrous Gluconage)
    Dosage: 650 mg (325 mg, 2 in 1 d), oral
    Administration route: Oral
    Indication: Iron Deficiency

Lortab
    Dosage: 1 dosage forms 6 hr)
    Indication: Product Used FOR Unknown Indication

Magnesium Citrate (Magnesium Citrate)
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Megace
    Dosage: oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Pioglitazone Hydrochloride
    Dosage: 30 mg (30 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ranitidine Hydrochloride
    Dosage: 300 mg (150 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication

Simvastatin
    Dosage: 80 mg (40 mg, 2 in 1 d) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Sunitinib Malate
    Dosage: 100 mg (50 mg, 2 in 1 d) oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Tessalon
    Dosage: 300 mg (100 mg, 3 in 1 d), oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Zofran
    Dosage: 1 dosage forms, 6 hr, oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Extra Strength Tylenol; Aspirin; Cipro; Actonel; Artificial Tears (Hypromellose)



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014